| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $352,047 ) |
| 2024 | 2024 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 4 | 8/9/2024 | NON-COMPETING CONTINUATION | $352,047 |
|
| Issue Date FY: 2023 ( Subtotal = $363,164 ) |
| 2023 | 2023 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 3 | 7/26/2023 | NON-COMPETING CONTINUATION | $363,164 |
|
| Issue Date FY: 2022 ( Subtotal = $370,575 ) |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 2 | 7/20/2022 | NON-COMPETING CONTINUATION | $370,575 |
|
| Issue Date FY: 2021 ( Subtotal = $370,575 ) |
| 2021 | 2021 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 1 | 8/10/2021 | NEW | $370,575 |
|
|